A promising approach towards personalized targeted therapy for pancreatic cancer using an innovative kinase activity profiling assay

被引：0
|
作者：
Rangarajan, S. [1 ]
de Hingh, I. H. J. T. [2 ]
Creemers, G. J. [2 ]
van den Brule, A. J. [3 ]
van der Hoeven, J. C. M. [1 ]
机构：
[1] VitrOm Healthcare Serv BV, sHertogenbosch, Netherlands
[2] Catharina Hosp, Eindhoven, Netherlands
[3] PAMM Reg Inst Pathol, Eindhoven, Netherlands
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [31] Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy
    Gupta, Preeti
    Mohammad, Taj
    Khan, Parvez
    Alajmi, Mohamed F.
    Hussain, Afzal
    Rehman, Md Tabish
    Hassan, Md Imtaiyaz
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [32] Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine
    Picker, Alexander
    Jackson, David B.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2011, 11 (06) : 567 - 577
  • [33] Pharmacokinetic profiling of Re-Phenformin in vivo: A novel approach in pancreatic cancer therapy
    Gholizadeh, Amir Mohammad
    Dai, Lu
    Dagher, Fatima
    Xiong, Chiyi
    Li, Chun
    Chow, Diana S-L
    CANCER RESEARCH, 2024, 84 (06)
  • [34] Systematic profiling of staralog response to acquired drug resistant kinase gatekeeper mutations in targeted cancer therapy
    Yang, Yuping
    Qiu, Yue
    Liu, Xu
    Liu, Yanhua
    Yin, Yaling
    Li, Peng
    AMINO ACIDS, 2020, 52 (04) : 511 - 521
  • [35] Systematic profiling of staralog response to acquired drug resistant kinase gatekeeper mutations in targeted cancer therapy
    Yuping Yang
    Yue Qiu
    Xu Liu
    Yanhua Liu
    Yaling Yin
    Peng Li
    Amino Acids, 2020, 52 : 511 - 521
  • [36] A novel non-toxic multi-targeted approach for pancreatic cancer therapy
    Sarkar, F.
    Banerjee, S.
    Wang, Z.
    Li, Y.
    Abbruzzese, J.
    PANCREAS, 2007, 35 (04) : 425 - 425
  • [37] PERSONALIZED THERAPY OF COLORECTAL CANCER PATIENTS ENROLLED IN PHASE 1 TRIALS WITH TARGETED AGENTS BASED ON MOLECULAR PROFILING OF TUMORS
    Dienstmann, R.
    Serpico, D.
    Sanchez-Olle, G.
    Elez, M. E.
    Alsina, M.
    Macarulla, T.
    Capdevila, J.
    Argiles, G.
    Perez-Garcia, J.
    Moreno, D.
    Murtra, N.
    Landolfi, S.
    Jimenez, J.
    Aura, C.
    Prudkin, L.
    Rodon, J.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 22 - 22
  • [38] In vitro evaluation of multi-targeted kinase inhibitors in scirrhous gastric cancer cell lines by tyrosine kinase activity profiling
    Koh, Yasuhiro
    Serizawa, Masakuni
    de Wijn, Rik
    Hilhorst, Riet
    Nakajima, Takako
    Yasui, Hirofumi
    Yanagihara, Kazuyoshi
    Dankers, Martijn
    Ruijtenbeek, Rob
    Boku, Narikazu
    CANCER RESEARCH, 2011, 71
  • [39] Original targeted therapy for the management of the burnout syndrome in nurses: an innovative approach and a new opportunity in the context of predictive, preventive and personalized medicine
    Simona Grigorescu
    Ana-Maria Cazan
    Liliana Rogozea
    Dan Ovidiu Grigorescu
    EPMA Journal, 2020, 11 : 161 - 176
  • [40] Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary
    Bayne, Harry E. Fuentes
    Kasi, Pashtoon M.
    Ma, Li
    Hart, Lowell L.
    Wong, Jenna
    Spigel, David R.
    Schnabel, Catherine A.
    Reeves, James A.
    Halfdanarson, Thorvardur R.
    Treuner, Kai
    Greco, F. Anthony
    JCO PRECISION ONCOLOGY, 2024, 8
12345